Check Back Soon

Progeria Clinical Trials Near You

Find progeria clinical trials near you. Get notified when new research studies begin recruiting in your area.

No progeria trials are recruiting right now

We refresh our data every hour. New studies are added regularly — check back tomorrow or search our full database for the latest.

Active Trials in Related Rare Disease Conditions

While we don't have progeria-specific trials right now, here are 20 recruiting studies in closely related conditions you may want to explore.

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Browse Related Conditions

About Progeria

Progeria (Hutchinson-Gilford progeria syndrome) is an extremely rare genetic disorder that causes children to age rapidly, developing conditions typically seen in the elderly. It is caused by a mutation in the LMNA gene. Lonafarnib is an FDA-approved treatment that may slow progression.

Why Clinical Trials Matter for Progeria

Clinical trials are essential for advancing treatment options for progeria. Through research studies, scientists and doctors develop new therapies, improve existing treatments, and discover better ways to diagnose and manage the condition.

  • Access to new treatments: Participants may receive promising therapies before they are widely available
  • Expert medical care: Trial participants are closely monitored by specialized research teams
  • Contributing to science: Your participation helps advance medical knowledge for future patients
  • No cost: Most trial-related procedures and treatments are provided at no charge

What to Expect from Future Progeria Trials

While there are currently no actively recruiting trials for progeria on our platform, new studies are registered and begin recruiting regularly. Here's what you can expect when trials become available:

  1. Screening: Review eligibility criteria to see if you may qualify
  2. Consent: Learn about the study details, risks, and benefits before agreeing to participate
  3. Enrollment: Complete baseline assessments with the research team
  4. Treatment: Receive the study intervention with regular monitoring
  5. Follow-up: Continue check-ins to track your health outcomes

About This Data

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated July 13, 2026 · Data from ClinicalTrials.gov